Friday, April 18, 2014 1:15:59 PM
Tuesday April 10, 2012 is date on the promojob and now go check time frame we started to here about the chill...yup about the same time they got hit with chill you get a hotstock promojob...
Isn't that nice like one last stab at the pigeons to bite.
http://thestockprofiler.com/hotstocks/pyct.html
Since licensing Flushaway® a new patent and sanitary products design was adopted reducing Cost of Goods, increasing margins, and providing better returns. Tests and trials following these improvements had teething troubles but the end results were successful.
• Product samples have been manufactured and distributed.
• Product branding has been improved.
• The Company has started commerical production and
is focusing on pursuing sales.
DO YOUR RESEARCH ON PYCT
PRODUCT HIGHLIGHTS
•Price competitive with majors in the industry
•New production processes reduced cost of goods delivering improved margins
•New utility patent registered with Patent Co-operation Treaty for international protection
•Established manufacturing arrangements in China; growing the manufacturing capacity, considerably reducing production costs and improving product quality.
•Received Canada’s highly acclaimed Environmental Choice EcoLogo™ certification.
•Independent flush ability test completed
•Independent Dispersion test completed
•Independent Biodegradability test completed under American Standards for Testing and Materials (ASTM D5988-03). Test requires biodegradable milestone is achieved in 180 days. Flushaway achieved the milestone in 70 days. Traditional product does not biodegrade and plastic is estimated to remain in landfill for 200 years or more.
•Sales of Flushaway® previously achieved in major US stores and other countries by CET.
•Samples have been produced and distributed.
•Flushaway has completed FDA registration
•A strategic supplier purchased select equipment for Flushaway production.
•Pilot production for Flushaway started.
•Commerical production started
•New brand added (Mibella)
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM